Abstract:IntroductionThe coronavirus disease 2019 (COVID-19) pandemic has affected billions of people worldwide, and the lessons learned need to be concluded to get better prepared for the next pandemic. Early identification of high-risk patients is important for appropriate treatment and distribution of medical resources. A generalizable and easy-to-use COVID-19 severity stratification model is vital and may provide references for clinicians.MethodsThree COVID-19 cohorts (one discovery cohort and two validation cohorts) were included. Longitudinal peripheral blood mononuclear cells were collected from the discovery cohort (n = 39, mild = 15, critical = 24). The immune characteristics of COVID-19 and critical COVID-19 were analyzed by comparison with those of healthy volunteers (n = 16) and patients with mild COVID-19 using mass cytometry by time of flight (CyTOF). Subsequently, machine learning models were developed based on immune signatures and the most valuable laboratory parameters that performed well in distinguishing mild from critical cases. Finally, single-cell RNA sequencing data from a published study (n = 43) and electronic health records from a prospective cohort study (n = 840) were used to verify the role of crucial clinical laboratory and immune signature parameters in the stratification of COVID-19 severity.ResultsPatients with COVID-19 were determined with disturbed glucose and tryptophan metabolism in two major innate immune clusters. Critical patients were further characterized by significant depletion of classical dendritic cells (cDCs), regulatory T cells (Tregs), and CD4+ central memory T cells (Tcm), along with increased systemic interleukin-6 (IL-6), interleukin-12 (IL-12), and lactate dehydrogenase (LDH). The machine learning models based on the level of cDCs and LDH showed great potential for predicting critical cases. The model performances in severity stratification were validated in two cohorts (AUC = 0.77 and 0.88, respectively) infected with different strains in different periods. The reference limits of cDCs and LDH as biomarkers for predicting critical COVID-19 were 1.2% and 270.5 U/L, respectively.ConclusionOverall, we developed and validated a generalizable and easy-to-use COVID-19 severity stratification model using machine learning algorithms. The level of cDCs and LDH will assist clinicians in making quick decisions during future pandemics.

scPheno: A deep generative model to integrate scRNA-seq with disease phenotypes and its application on prediction of COVID-19 pneumonia and severe assessment

Tracing the cell-type-specific modules of immune responses during COVID-19 progression using scDisProcema

Identification of cell types, states and programs by learning gene set representations

Inferring microenvironmental regulation of gene expression from single-cell RNA sequencing data using scMLnet with an application to COVID-19

CloudPred: Predicting Patient Phenotypes From Single-cell RNA-seq

Phenotype prediction from single-cell RNA-seq data using attention-based neural networks

Extraction of biological signals by factorization enables the reliable analysis of single-cell transcriptomics

Identification of Gene Markers Associated with COVID-19 Severity and Recovery in Different Immune Cell Subtypes.

SCINA: Semi-Supervised Analysis of Single Cells in silico

scPanel: A tool for automatic identification of sparse gene panels for generalizable patient classification using scRNA-seq datasets

A Generalizable and Easy-to-use COVID-19 Stratification Model for the Next Pandemic Via Immune-Phenotyping and Machine Learning

Neutrophil-based single-cell sequencing combined with transcriptome sequencing to explore a prognostic model of sepsis

A Machine Learning Model for the Prediction of COVID-19 Severity Using RNA-Seq, Clinical, and Co-Morbidity Data

Identification of cuproptosis-related molecular subtypes and a novel predictive model of COVID-19 based on machine learning

Identification of COVID-19 severity biomarkers based on feature selection on single-cell RNA-Seq data of CD8+ T cells.

Identification of Transcriptome Biomarkers for Severe COVID-19 with Machine Learning Methods

Recognition of Immune Cell Markers of COVID-19 Severity with Machine Learning Methods

An application based on bioinformatics and machine learning for risk prediction of sepsis at first clinical presentation using transcriptomic data

Identification of Marker Genes in Infectious Diseases from ScRNA-seq Data Using Interpretable Machine Learning

A single-cell atlas of the peripheral immune response in patients with severe COVID-19